Cannabidiol (CBD) Market Size, Share & Trends Analysis Report By Source Type (Hemp, Marijuana), By Product Type (CBD Oil, CBD Capsules, CBD Topicals, CBD Tinctures, CBD Vape Products, Others), By Application (Tincture, Food, Beverages, Pharmaceutical, Topicals, Dietary Supplements, Others), By Distribution Channel (Online, Offline) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Cannabidiol (CBD) Market Size & Growth Analysis

The global cannabidiol market size was valued at USD 9.95 billion in 2025 and is projected to grow from USD 11.55 billion in 2026 to USD 38.07 billion by 2034, registering a CAGR of 16.08% during the forecast period from 2026 to 2034. North America dominated the cannabidiol market with a market share of 42% in 2025.

Cannabidiol (CBD) is a natural compound extracted from the hemp plant that is widely used in wellness, personal care, pharmaceutical, and nutraceutical products. It is commonly found in oils, capsules, creams, beverages, and supplements. Demand is growing due to increasing consumer interest in natural wellness products, expanding research on CBD applications, and changing regulations supporting the use of hemp-derived products.

Cannabidiol Market Segmentation Analysis

By Source Type

The hemp segment dominated the cannabidiol (CBD) market with a market share of 68% in 2025 and is also expected to register the fastest CAGR of 15.8% during the forecast period 2026–2034. Its leading position is supported by broader commercial use across wellness, personal care, food, and formulation applications, together with easier integration into large-scale CBD manufacturing.

The marijuana segment remains relevant in regulated medical and adult-use markets where higher-cannabinoid formulations and specialized product formats are permitted.

Request Customizationto receive a tailored report.

By Product Type

The CBD oil segment dominated the cannabidiol (CBD) market with a market share of 34% in 2025, supported by its flexibility across direct consumption, formulation, and incorporation into other CBD-based products. Its simple dosing format and wide availability across consumer wellness categories continue to support its strong market position.

The CBD topicals segment is expected to grow at the fastest CAGR of 16.9% during the forecast period 2026–2034, driven by wider use in creams, balms, lotions, and other localized personal-care formats. CBD capsules serve consumers seeking standardized portions, while tinctures remain relevant for measured liquid use. CBD vape products and other formats address narrower product preferences and specialized consumption occasions.

By Application

The pharmaceutical segment dominated the cannabidiol (CBD) market with a market share of 22% in 2025, supported by controlled formulation requirements, clinical product development, and the use of CBD in regulated therapeutic applications. Greater emphasis on product consistency, dosing precision, and quality standards strengthens its position within this segment.

The topicals segment is expected to register the fastest CAGR of 17.1% during the forecast period 2026–2034, supported by the incorporation of CBD into skincare, recovery, and localized wellness products. Tincture applications remain important for liquid formulations, while food and beverages broaden CBD use through edible formats. Dietary supplements and other applications continue to serve additional wellness and specialty product categories.

By Distribution Channel

The online segment dominated the cannabidiol (CBD) market with a market share of 58% in 2025 and is also expected to grow at the fastest CAGR of 16.8% during the forecast period 2026–2034. Its strong position is supported by direct-to-consumer brand models, broader product visibility, easier comparison across formulations, and convenient access to product information.

The offline segment continues to serve consumers through pharmacies, specialty stores, wellness retailers, and other physical outlets where in-person guidance and immediate product availability remain important.

Speak to an Analystto discuss market opportunities.

Cannabidiol (CBD) Market Regional Outlook

North America Cannabidiol Market Analysis

The North America cannabidiol market accounted for the largest regional share of 42% in 2025, supported by established regulatory frameworks, pharmaceutical research, product-quality requirements, and a developed hemp-processing ecosystem. In the U.S., FDA oversight remains central to the market, with only specific CBD-containing drug products approved for medical use while other therapeutic claims remain subject to federal restrictions, keeping compliance and clinical evidence important for market participants.

The Canada cannabidiol market operates under the Cannabis Act, with CBD production, processing, distribution, and sale subject to federal and provincial controls. Health Canada is also exploring a potential regulatory pathway for certain non-prescription CBD-containing health products, which could reshape the country’s regulated health-product segment if implemented.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Cannabidiol Market Analysis

The Europe cannabidiol market is expected to register the fastest CAGR of 17.8% during the forecast period, while regulatory assessment and product authorization remain major factors shaping commercial development. In the U.K., CBD foods are treated as novel foods and require authorization, with the Food Standards Agency maintaining a register of products linked to applications undergoing regulatory review.

The Germany and France cannabidiol markets are influenced by the broader EU novel-food framework, under which CBD extracts and isolates are classified as novel foods and therefore require regulatory assessment before qualifying food applications can enter the market. Several CBD novel-food authorization procedures were also terminated by the European Commission during 2026, reinforcing the importance of product evidence and regulatory compliance for companies operating across Europe.

Cannabidiol (CBD) Market Competitive Landscape

The cannabidiol (cbd) market is highly fragmented, with cannabis-focused companies, nutraceutical manufacturers, pharmaceutical developers, personal care brands, and regional CBD suppliers competing across oils, capsules, beverages, cosmetics, and therapeutic formulations. Leading players include Charlotte’s Web Holdings, Inc., Jazz Pharmaceuticals plc, CV Sciences, Inc., Medical Marijuana, Inc., and Aurora Cannabis Inc., which together are estimated to account for approximately 20–25% of the global cannabidiol (cbd) market share.

Established players compete through brand recognition, product quality, regulatory compliance, and broad distribution networks. Emerging and regional players within the Cannabidiol (CBD) Market ecosystem compete through competitive pricing, specialized formulations, localized product portfolios, and direct-to-consumer channels, helping them build positions in niche wellness and personal care segments.

List of Key and Emerging Players in Cannabidiol (CBD) Market